Package 67457-583-04

Brand: fondaparinux sodium

Generic: fondaparinux sodium
NDC Package

Package Facts

Identity

Package NDC 67457-583-04
Digits Only 6745758304
Product NDC 67457-583
Product ID 67457-583_40824645-13d9-4302-9b37-fcc3dc64b4a6
Description

10 SYRINGE, GLASS in 1 CARTON (67457-583-04) / .4 mL in 1 SYRINGE, GLASS (67457-583-00)

Marketing

Marketing Status
Marketed Since 2015-01-05
Brand fondaparinux sodium
Generic fondaparinux sodium
Sample Package No

Linked Drug Pages (1)

Fondaparinux Sodium ndc-match (0.95)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["SUBCUTANEOUS"], "spl_id": "40824645-13d9-4302-9b37-fcc3dc64b4a6", "openfda": {"unii": ["X0Q6N9USOZ"], "rxcui": ["861356", "861360", "861363", "861365"], "spl_set_id": ["4b65f642-87f7-4da5-a9c9-02cd1f8d9d16"], "manufacturer_name": ["Mylan Institutional LLC"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "10 SYRINGE, GLASS in 1 CARTON (67457-583-04)  / .4 mL in 1 SYRINGE, GLASS (67457-583-00)", "package_ndc": "67457-583-04", "marketing_start_date": "20150105"}], "brand_name": "Fondaparinux Sodium", "product_id": "67457-583_40824645-13d9-4302-9b37-fcc3dc64b4a6", "dosage_form": "INJECTION, SOLUTION", "pharm_class": ["Factor Xa Inhibitor [EPC]", "Factor Xa Inhibitors [MoA]"], "product_ndc": "67457-583", "generic_name": "fondaparinux sodium", "labeler_name": "Mylan Institutional LLC", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Fondaparinux Sodium", "active_ingredients": [{"name": "FONDAPARINUX SODIUM", "strength": "5 mg/.4mL"}], "application_number": "NDA021345", "marketing_category": "NDA AUTHORIZED GENERIC", "marketing_start_date": "20150105", "listing_expiration_date": "20261231"}